Clinical trials
Age clinical trials
Below are recruiting age clinical trials, each written for real people, not researchers. We’re tracking 1,275 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06381414Recruiting
Childhood early oral aging: causes and effects on teeth
This study looks at why some young children have early signs of oral aging and how it affects their bite. It aims to find the causes and possible consequences for kids ages 3 to 6.
São Paulo, São PauloAges 3–6 - NCT07630649RecruitingPhase 2
Gene therapy for wet age-related macular degeneration in second eye
This study tests a one-time gene therapy injection (ixoberogene soroparvovec) in the second eye of people with wet age-related macular degeneration who have already responded well to anti-VEGF injections. The goal is to see if this gene therapy can help preserve or improve vision in that eye.
Phoenix, ArizonaAges 50 years+ - NCT06697288Recruiting
Sunscreen vs. usual routine for signs of aging
This study tests whether a specific sunscreen can reduce signs of skin aging on the face more than your normal routine. If you have moderate to advanced signs of aging and want to see if a new sunscreen can help, this might be for you.
Rio de JaneiroAges 30–60 - NCT07623785Recruiting
Beef and Brain Health in Older Adults
This study looks at whether eating lean beef and dairy products daily affects brain health markers in people 65 and older. Researchers will track blood, urine, and other samples to see if beef consumption influences how your brain functions at the molecular level.
Brookings, South DakotaAges 65 years+ - NCT07614776RecruitingPhase 3
New Eye Injection Treatment for Age-Related Macular Degeneration
This study tests whether a new eye injection called ABP 938 works as well as or better than the current standard treatment (Eylea) for wet age-related macular degeneration—a condition that causes vision loss in the center of your sight. You would receive injections into your eye every month for a year.
Fullerton, CaliforniaAges 50 years+ - NCT05672121RecruitingPhase 1/Phase 2
Gene therapy safety study for neovascular macular degeneration
This trial tests a new gene therapy drug (KH631) to see if it is safe and tolerated in people with neovascular age-related macular degeneration (nAMD). It may help your retina problems, but the early goal is mainly to learn about side effects and how the treatment behaves in the eye.
BeijingAges 50–85 - NCT06458595RecruitingPhase 1/Phase 2
Gene therapy for wet age-related macular degeneration (nAMD)
This trial tests a gene therapy (KH658) as a one-time treatment for wet macular degeneration. It's for people whose condition has been stabilized with anti-VEGF injections, and aims to see if it is safe and can reduce the need for frequent eye injections.
TianjinAges 50–85 - NCT07605182Recruiting
Sperm Sorting Device to Improve IVF Success in Older Fathers
This study tests whether a special device that selects the most active sperm can improve IVF success rates when the male partner is 40 or older. The goal is to see if this sorting technique, combined with genetic testing of embryos, leads to healthier pregnancies.
Hà Nội, Ha DongAges 40 years+ - NCT07600450RecruitingPhase 1
First study of a new drug in healthy adults
This study tests a new investigational drug to see how safe it is and how the body processes it. It is one of the first steps in drug development, and it helps determine if the drug is suitable for further testing.
GroningenAges 25–55 - NCT01224886Recruiting
Study of age-related insulin resistance and exercise
This study looks at how age affects the way your body uses insulin (a hormone that helps move sugar into cells), and how lifestyle or exercise may change that. It may help you understand insulin resistance and whether changes in activity could improve blood sugar control.
BernAges 60–80 - NCT07591337Recruiting
Study of Aging Blood Vessels and a Protein Called SNRK
This research study examines how blood vessels age over time and how a protein called SNRK may be involved in that process. Researchers want to understand vascular aging (how blood vessels become less flexible as we get older) to potentially help prevent heart and stroke problems.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07587515RecruitingPhase 1/Phase 2
New Eye Drop Treatment for Wet Age-Related Macular Degeneration
This study tests a new experimental eye drop (EYC-0305) for wet AMD, a common cause of vision loss in older adults. The goal is to see if it can slow or prevent further damage to central vision.
Beverly Hills, CaliforniaAges 50 years+ - NCT05043753Recruiting
Ultrasound screening for abnormal baby growth late in pregnancy
This trial studies whether a specific ultrasound approach can better detect problems with fetal (baby) growth in the later part of pregnancy. It may help identify concerns earlier so your care team can plan the next steps.
Modena, ModenaAges 18–45 - NCT07579845Recruiting
Dietary supplement study on aging markers and body health
This study tests whether a dietary supplement containing humic and fulvic acids (natural compounds) can improve markers of biological aging, inflammation, and how your body handles toxins. Researchers will check blood samples to see if the supplement affects these markers over time.
Richmond, VirginiaAges 40 years+ - NCT07569120Recruiting
Brain Chemistry and Aging: Healthy and Parkinson's Study
This research uses brain imaging scans to study how a chemical messenger in the brain (called noradrenaline) changes as people age and in Parkinson's disease. The goal is to better understand how this brain system works and may help develop future treatments.
BronAges 20–80 - NCT07568951Recruiting
Hip Muscle Strength Study in Parkinson's Disease
This study compares how hip muscles work in people with and without Parkinson's disease. Researchers will measure your hip muscle strength and control to better understand how Parkinson's affects movement and balance.
TaoyuanAges 20–85 - NCT07567482Recruiting
Exoskeleton-Assisted Walking for Parkinson's and Aging
This study tests whether a wearable robotic exoskeleton (a powered leg device) can help people with Parkinson's disease and older adults walk better and stay active. Researchers want to see if this technology improves mobility and reduces fall risk.
Gatineau, QuebecAges 50 years+ - NCT07547228RecruitingPhase 1/Phase 2
PRL3-zumab for advanced age-related macular degeneration
This study tests a new injectable medicine called PRL3-zumab for patients with advanced wet macular degeneration (nAMD) whose condition hasn't improved enough with standard treatments. The goal is to see if this new approach can help preserve or improve vision in people who have already tried at least two other eye injections.
SingaporeAges 18 years+ - NCT07516132RecruitingPhase 3
Long-term safety study of axitinib implant for wet macular degeneration
This study follows people who completed an earlier 2-year trial of OTX-TKI, a small implant placed in the eye to treat wet age-related macular degeneration (a condition causing vision loss). Researchers want to make sure the treatment remains safe over time.
Bakersfield, CaliforniaAges 50 years+ - NCT07513298Recruiting
Video Game Exercise for Overweight Children's Fitness
This study tests whether playing specially designed Wii video games that involve aerobic exercise can help overweight children improve their reaction time and lung function. The goal is to see if gaming-based exercise can be an engaging way for kids to get healthier.
CairoAges 10–15 - NCT07502742Recruiting
Pain in aging athletes and nonathletes
This study looks at how pain affects older adults who are either current master's athletes, former competitive athletes, or nonathletes. It aims to understand why some people have more pain and what helps them stay active.
Milwaukee, WisconsinAges 35–65 - NCT07500324Recruiting
Searching for new markers in age-related eye diseases
This study looks for proteins in the blood and eye fluids that may help doctors better understand and monitor three common eye conditions: age-related macular degeneration, diabetic retinopathy, and retinal detachment. If you have one of these conditions, or if you are a healthy control with no retinal disease, you may be able to help by giving a small sample of blood or fluid from your eye during a routine procedure.
Roma, ItalyAges 18 years+ - NCT07482176RecruitingPhase 3
Gene therapy trial for wet age-related macular degeneration
This trial tests a one-time gene therapy injection (IXO-vec) for people with wet age-related macular degeneration (nAMD). It aims to reduce the need for frequent eye injections by helping the eye make its own medicine to block the growth of harmful blood vessels.
Mesa, ArizonaAges 50 years+ - NCT07482657RecruitingPhase 2
Zelicapavir for RSV in infants and toddlers
This trial tests a new medicine called Zelicapavir for babies and young children (28 days to 3 years old) who have respiratory syncytial virus (RSV) infection. The medicine aims to help them recover faster and with fewer complications.
BangkokAges 4 weeks–3 years
Hear when a new Age trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for age?
- Yes. Clin2 currently lists 1,275 recruiting age studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a age trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a age trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.